UBS Maintains Neutral on Exelon, Raises Price Target to $43
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Daniel Ford maintains a Neutral rating on Exelon (NASDAQ:EXC) but raises the price target from $40 to $43.
September 20, 2024 | 1:57 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS analyst Daniel Ford maintains a Neutral rating on Exelon but raises the price target from $40 to $43, indicating a slightly more positive outlook.
The increase in the price target from $40 to $43 suggests a slightly more optimistic view on Exelon's future performance, which could positively influence investor sentiment and potentially lead to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100